Latest News

And it's not the one you're probably thinking of.

Connect Biopharma (NASDAQ:CNTB) reported top-line results from its Seabreeze STAT Phase II study of rademikibart in patients experiencing acute exacerbations of chronic obstructive pulmonary disease, or COPD. The company said the study met its primary objective, showing reductions in treatment failu

Soon enough, seniors could get more leeway to earn money while collecting benefits.

Unit volumes tell the story of which EV start-up can survive.

IonQ and Alphabet are two completely different investments.

Rafael (NYSE:RFL) reported top-line results from its pivotal Phase III TransportNPC study evaluating Trappsol Cyclo for Niemann-Pick Disease Type C, a rare, progressive genetic disorder. The company said it remains on track to submit a New Drug Application to the U.S. Food and Drug Administration in

Micron's revenue surged 432% over two years while Qualcomm's declined, widening a gap that raises questions about sector dynamics and competitive positioning.

Cameco's stock has fallen from $134 to $85, but that drop could be an opportunity for investors looking to invest in nuclear power.

XPH delivered 19% higher returns over five years despite half the volatility. XBI's 165 holdings offer broader exposure but with a 53% maximum drawdown.

Inventiva (NASDAQ:IVA) said it expects to report top-line results in the fourth quarter of 2026 from its fully enrolled Phase III NATiV3 trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, or MASH. Chief Executive Officer Andrew Obenshain said the final patient

Nvidia is in command of the AI arms race.

Nokia trades at a steep premium valuation while Verizon generates nearly 13x more net income on a 12.4% margin, a stark contrast in profitability and value.

AI storage needs are accelerating -- and both of these companies are perfectly positioned to benefit.

Howard Hughes (NYSE:HHH) shareholders elected all 11 board nominees, approved the company’s advisory executive-compensation proposal and ratified KPMG as independent auditor for 2026, according to preliminary results announced at the company’s annual meeting. Executive Chair Bill Ackman said each d

The new Federal Reserve chair still has a lot to prove, and political factors are making that harder.

Peoples Bancorp (NASDAQ:PEBO) has agreed to acquire Rockville, Maryland-based Capital Bancorp Inc. in an all-stock transaction valued at approximately $728 million, a deal management described as transformational because it would add scale, national specialty businesses and a more diversified earnin

As investors look for ways to diversify, Bitcoin could soar to new highs.

Both brokers keep drawing in new money. But just one of the two stocks is cheap.

Liberty Silver (OTCMKTS:BHLL) outlined plans to combine Bunker Hill and Silver47, a transaction the company said would create a U.S.-focused, multi-asset mining company centered on silver and other strategic metals. During the presentation, the company said Bunker Hill has entered production at its

The AI build-out isn't slowing down anytime soon.

Alphabet trades at a lower valuation multiple despite slower growth, while Meta invests heavily in hardware amid regulatory headwinds.

Sagimet Biosciences (NASDAQ:SGMT) said its licensed partner Ascletis reported positive 52-week results from an open-label extension study of denifanstat, an oral fatty acid synthase, or FASN, inhibitor being evaluated for moderate-to-severe acne vulgaris in China. The company also outlined plans fo

Cramer was a successful hedge fund manager and has been a market pundit on CNBC for decades.

Grindr (NYSE:GRND) said it has agreed to acquire PurposeMed Inc., the parent company of Freddie, a Canadian telehealth provider of HIV pre-exposure prophylaxis, or PrEP, that is expanding in the United States. Chief Executive Officer George Arison described the transaction as the company’s first ma

The streamer's share of TV time keeps slipping. Is its revenue next?